Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Overleving patiënten met galblaaskanker beperkt verbeterd
jun 2020 | Maag-darm-leveroncologie